TrialViruses2018

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection.

Teresa I Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.